Aurelie Wingert-Fuchs

Aurelie Wingert-Fuchs has a diverse work experience spanning various industries and roles. Aurelie currently works at Pierre Fabre Group as the Head of Quality for R&D and Medical Business Units. Prior to that, they held the position of Head of Quality within the "Corporate Medical & Patient/Consumer" Division at the same company.

Before joining Pierre Fabre Group, Aurelie worked at DBV Technologies as the Senior Director of Clinical and Pharmacovigilance Quality Assurance for three years. Aurelie was responsible for overseeing the quality assurance activities in clinical and pharmacovigilance departments.

Aurelie also gained extensive experience in quality assurance and clinical affairs at LivaNova, where they served as the Global Clinical Quality Assurance Director. Aurelie was responsible for various activities such as managing competent authorities inspections, conducting audits, implementing quality metrics, and ensuring compliance with regulations.

Prior to LivaNova, Aurelie worked as the Clinical Quality Assurance Leader at Sorin Group, where they managed quality activities in the clinical affairs department.

Earlier in their career, Aurelie gained experience in international clinical project management at Sanofi and worked as Senior CRA/Clinical Project Manager at MDS Pharma Services. Aurelie started their career as a Cosmetics R&D Technician at Payot.

Overall, Aurelie Wingert-Fuchs' work experience showcases their expertise in quality assurance, clinical affairs, and project management across various industries.

Aurelie Wingert-Fuchs holds a MSc (Maîtrise) in Biochemistry from the University of Strasbourg, completed from 1990 to 1994. Aurelie also has a MSc (DESS) in Pharmacology from Université Paris-Est Marne-la-Vallée, completed from 1994 to 1996. In addition, they earned a DU in Statistics for Clinical Trials from Pierre and Marie Curie University, completed in 2005.